These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20656359)

  • 1. Patient information leaflets for antidepressants: are patients getting the information they need?
    Haw C; Stubbs J
    J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Australian dermatological postoperative patient information leaflets: Should we have a national checklist?
    Hunt WT; O'Sullivan NA; Donnelly A
    Australas J Dermatol; 2018 May; 59(2):118-123. PubMed ID: 28425573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
    Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
    Trials; 2014 Feb; 15():62. PubMed ID: 24548781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey.
    Harris K; Dickinson R; Raynor DK; MacDonald J; Knapp P
    Drug Saf; 2015 Aug; 38(8):721-7. PubMed ID: 26100144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
    Burgers C; Beukeboom CJ; Sparks L; Diepeveen V
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):137-43. PubMed ID: 25044310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How readable are orthodontic patient information leaflets?
    Harwood A; Harrison JE
    J Orthod; 2004 Sep; 31(3):210-9; discussion 201. PubMed ID: 15489365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient information: community pharmacy needs and perspectives.
    Juergens JP; Basara LR
    Top Hosp Pharm Manage; 1994 Oct; 14(3):47-57. PubMed ID: 10138928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using alternative methodologies for evaluating patient medication leaflets.
    Krass I; Svarstad BL; Bultman D
    Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Saint John's Wort as an antidepressant].
    Schulte PF
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1820-5. PubMed ID: 11020834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
    Cuddihy L; Howick J; Murphy E; Shiely F
    Trials; 2024 May; 25(1):292. PubMed ID: 38693579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient information leaflets and package inserts of ibuprofen provided in the UK and Thailand: a comparative assessment.
    Nualdaisri P; Corlett SA; Krska J
    Int J Pharm Pract; 2024 May; 32(3):208-215. PubMed ID: 38442896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of patient information leaflets incorporating patient diversity considerations: Varicocele embolisation and fluoroscopy guided joint injection examinations.
    Vassallo T; Mizzi A; Depasquale R; Maher M; Rainford L
    Radiography (Lond); 2018 Oct; 24 Suppl 1():S20-S27. PubMed ID: 30166004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The administration of St. John's wort (Hypericum perforatum) in the treatment of depression].
    Koszewska I
    Psychiatr Pol; 2001; 35(2):199-210. PubMed ID: 11490885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatological postoperative patient information leaflets: is it time for more uniformity?
    Hunt WT; McGrath EJ
    Clin Exp Dermatol; 2015 Oct; 40(7):747-52. PubMed ID: 26271961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of patient information leaflets provided by a district general hospital by the Flesch and Flesch-Kincaid method.
    Williamson JM; Martin AG
    Int J Clin Pract; 2010 Dec; 64(13):1824-31. PubMed ID: 21070533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much information about the benefits of medicines is included in patient leaflets in the European Union? - A survey.
    Dickinson R; Raynor DK; Knapp P; MacDonald J
    Int J Pharm Pract; 2017 Apr; 25(2):147-158. PubMed ID: 27405658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.